Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: Clinical efficacy and more

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 59, Issue 11, 2004, Pages 1205-1210

  Marogna, M ^a   Spadolini, I ^b   Massolo, A ^c   Canonica, G W ^d   Passalacqua, G ^d  

^a OSPEDALE DI CIRCOLO   (Italy)

^b Anallergo SpA   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Adherence; Bronchial hyperreactivity; Preventive effect; Respiratory allergy; Sublingual immunotherapy

Indexed keywords

ANTIGEN; BECLOMETASONE DIPROPIONATE; CETIRIZINE; CROMOGLYCATE DISODIUM; LORATADINE; SALBUTAMOL;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SKIN SENSITIZATION;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; ALLERGENS; ASTHMA; BRONCHIAL HYPERREACTIVITY; CHILD; CHILD, PRESCHOOL; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNOTHERAPY; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RESPIRATORY HYPERSENSITIVITY; RHINITIS; TREATMENT OUTCOME;

EID: 6344237121     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2004.00508.x     Document Type: Article

References (34)

1. BOUSQUET J, LOCKEY R, MALLING HJ (eds). World Health Organization Position Paper. Allergen immunotherapy: therapeutical vaccines for allergic diseases. Allergy 1998;53(Suppl. 44):20-27.
2. ABRAMSON M, PUY R, WEINER J. Immunotherapy in asthma: an updated systematic review. Allergy 1999;54:1022-1041.
3. LOCKEY RF, NICOARA-KASTI GL, THEODOROPOULOS DS, BUKANTZ SC. Systemic reactions and fatalities associated with allergen immunotherapy. Ann Allergy Asthma Immunol 2001;87(Suppl. 1):47-55.
4. KAGI MK, WUTRICH B. Different methods of local allergen immunotherapy. Allergy 2002;57:379-388.
5. CANONICA GW, PASSALACQUA G. Non-injection routes of immunotherapy. J Allergy Clin Immunol 2003;111:437-448.
6. WILSON DR, TORRES LI, DURHAM SR. Sublingual immunotherapy for allergic rhinitis (Cochrane review). Cochrane Database Syst Rev 2003;2:CD002893.
7. DI RIENZO V, PAGANI A, PARMIANI S, PASSALACQUA G, CANONICA GW. Post-marketing surveillance study on the safety of sublingual immunotherapy in children. Allergy 1999;54:1110-1113.
8. LOMBARDI C, GARGIONI S, MELCHIORRE A, TIRI A, FALAGIANI P, CANONICA GW et al. Safety of sublingual immunotherapy in adults: a post marketing surveillance study. Allergy 2001;56:889-892.
9. ANDRE' C, VATRINET C, GALVAIN S, CARAT F, SICARD H. Safety of sublingual swallow immunotherapy in children and adults. Int Arch Allergy Immunol 2000;121:229-234.
10. BOUSQUET J, VANCAUWENBERGE P (editors). Allergic rhinits and its impact on asthma. J Allergy Clin Immunol 2001;107(suppl.):240-245.
11. MALLING HJ. Allergen-specific immunotherapy in allergic rhinitis. Curr Opin Allergy Clin Immunol 2001;1:43-46.
12. DES-ROCHES A, PARADIS L, MÉNARDO J-L, BOUGES S, DAURÉS J-P, BOUSQUET J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitisations in children. J Allergy Clin Immunol 1997;99:450-453.
13. MOLLER C, DREBORG S, FERDOUSI HA, HALKEN S, HOST A, JACOBSEN L et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 2002;109:251-256.
14. NIH. Global initiative for asthma: guidelines for the diagnosis and management of asthma. NIH publication 97-4051, 1997.
15. DREBORG S, FREW A. Position paper: allergen standardization and skin tests. Allergy 1993;48(Suppl. 14):49-82.
16. HARGREAVE FE, RYAN G, THOMSON NC. Bronchial responsiveness to histamine and methacholine in asthma: measurement and clinical significance. J Allergy Clin Immunol 1981;68:347-355.
17. STERK PJ, FABBRI LM, QUANJER PH, COCKCROFT DW, O'BYRNE PM, ANDERSON SD et al. Airway responsiveness. Standardized challenge tests with pharmacological, physical and sensitizing stimuli. Eur Resp J 1993;6:53-58.
18. CIPRANDI G, RICCA V, LANDI M, PASSALACQUA G, BAGNASCO M, CANONICA GW. Allergen-specific nasal challenge: response kinetics of clinical and inflammatory events to rechallenge. Int Arch Allergy Immunol 1998;115:157-161.
19. SOKAL RR, ROHLF FJ. Biometry. The principles and practice of statistics in biological research, 3rd edn. New York: WH Freeman & C, 1995.
20. GOOD P. Permutation tests: a practical guide to resampling methods for testing hypotheses, 2nd edn. New York: Springer Verlag, 2002.
21. SIEGEL S. CASTELLAN NJ. Nonparametric statistics for the behavioral sciences, 2nd edn. New York: Mc Graw-Hill, 1998.
22. SPSS Inc. SPSS Advanced Models 9.0. Chicago: SOSS Inc, 1999:497.
23. LIMA MT, WILSON D, PITKIN L, ROBERTS A, NOURI-ARIA K, JACOBSON M et al. Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial. Clin Exp Allergy 2002;32:507-514.
24. PASSALACQUA G, ALBANO M, FREGONESE L, MELA GS, CANONICA GW. Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite induced rhinoconjunctivitis. Lancet 1998;351:629-632.
25. PASSALACQUA G, ALBANO M, RICCIO AM, FREGONESE L, PUCCINELLI P, PERMIANI S et al. Clinical and immunological effects of a rush sublingual immunotherapy to parietaria species: a double blind placebo controlled trial. J Allergy Clin Immunol 1999;104:964-968.
26. PAJNO G, BARBERIO G, DE LUCA F, MORABITO L, PARMIANI S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 2001;31:1392-1397.
27. PURELLO D'AMBROSIO F, GANGEMI S, MERENDINO RA, ISOLA S, PUCCINELLI P, PARMIANI S et al. Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study. Clin Exp Allergy 2001;31:1295-1302.
28. FREW AJ, SMITH HE. Sublingual immunotherapy. J Allergy Clin Immunol 2001; 107:441-444.
29. LEE SY, KIM SJ, KWON SS, KIM YK, MOON HS, SONG JS et al. Relation of airway reactivity and sensitivity with bronchial pathology in asthma. J Asthma 2002;39:537-544.
30. LOMBARDI C, GARGIONI S, VENTURI S, ZOCCALI P, CANONICA GW, PASSALACQUA G. Controlled study of preseasonal immunotherapy with grass pollen extract in tablets: effect on bronchial hyperreactivity. J Investig Allergol Clin Immunol 2001;11:41-45.
31. GREMBIALE RD, CAMPOROTA L, NATY S, TRANFA CM, DJUKANOVIC R, MARSICO SA. Effects of specific immunotherapy in allergic rhinitic individuals with bronchial hyperresponsiveness. Am J Respir Crit Care Med 2000;162:2048-2052.
32. DI RIENZO V, MARCUCCI F, PUCCINELLI P, PARMIANI S, FRATI F, SENSI L et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a ten year prospective study. Clin Exp Allergy 2003;33: 206-210.
33. ALESSANDRO F, VINCENZO ZG, MARCO S, MARCELLO G, ENRICA R. Compliance with pharmacologic prophylaxis and therapy in bronchial asthma. Ann Allergy 1994;73:135-140.
34. KLEIJNEN J, DE CRAEN AJ, VAN EVERDINGEN J, KROL L. Placebo effect in double blind clinical trials: a review of it interaction with medications. Lancet 1994;344:1347-1349.